No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪704.68 B‬INR
‪19.28 B‬INR
‪246.38 B‬INR
‪281.54 M‬
Beta (1Y)


Kambam Nithyananda Reddy
Employees (FY)
‪33.41 K‬
Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AUROPHARMA is 1218.25 INR — it has increased by 1.32% in the past 24 hours. Watch AUROBINDO PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AUROBINDO PHARMA stocks are traded under the ticker AUROPHARMA.
AUROPHARMA stock has risen by 2.56% compared to the previous week, the month change is a 9.85% rise, over the last year AUROBINDO PHARMA has showed a 107.89% increase.
We've gathered analysts' opinions on AUROBINDO PHARMA future price: according to them, AUROPHARMA price has a max estimate of 1400.00 INR and a min estimate of 980.00 INR. Watch AUROPHARMA chart and read a more detailed AUROBINDO PHARMA stock forecast: see what analysts think of AUROBINDO PHARMA and suggest that you do with its stocks.
AUROPHARMA reached its all-time high on May 18, 2024 with the price of 1212.00 INR, and its all-time low was 4.60 INR and was reached on Jan 4, 1999. View more price dynamics on AUROPHARMA chart.
See other stocks reaching their highest and lowest prices.
AUROPHARMA stock is 3.53% volatile and has beta coefficient of 0.70. Track AUROBINDO PHARMA stock price on the chart and check out the list of the most volatile stocks — is AUROBINDO PHARMA there?
Today AUROBINDO PHARMA has the market capitalization of ‪704.68 B‬, it has increased by 0.08% over the last week.
Yes, you can track AUROBINDO PHARMA financials in yearly and quarterly reports right on TradingView.
AUROBINDO PHARMA is going to release the next earnings report on May 25, 2024. Keep track of upcoming events with our Earnings Calendar.
AUROPHARMA earnings for the last quarter are 16.04 INR per share, whereas the estimation was 15.39 INR resulting in a 4.26% surprise. The estimated earnings for the next quarter are 15.15 INR per share. See more details about AUROBINDO PHARMA earnings.
AUROBINDO PHARMA revenue for the last quarter amounts to ‪73.52 B‬ INR despite the estimated figure of ‪73.75 B‬ INR. In the next quarter revenue is expected to reach ‪73.27 B‬ INR.
AUROPHARMA net income for the last quarter is ‪9.36 B‬ INR, while the quarter before that showed ‪7.57 B‬ INR of net income which accounts for 23.65% change. Track more AUROBINDO PHARMA financial stats to get the full picture.
AUROBINDO PHARMA dividend yield was 0.58% in 2022, and payout ratio reached 9.12%. The year before the numbers were 1.35% and 19.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 21, 2024, the company has ‪33.41 K‬ employees. See our rating of the largest employees — is AUROBINDO PHARMA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUROBINDO PHARMA EBITDA is ‪51.58 B‬ INR, and current EBITDA margin is 15.50%. See more stats in AUROBINDO PHARMA financial statements.
Like other stocks, AUROPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUROBINDO PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUROBINDO PHARMA technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUROBINDO PHARMA stock shows the strong buy signal. See more of AUROBINDO PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.